Treace Medical Concepts (TMCI) Share-based Compensation (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Share-based Compensation came in at $8.0 million in Q1 2026, down 7.58% YoY from $8.7 million in Q1 2025, and up 131.67% on a QoQ basis from -$25.4 million in Q4 2025.
Treace Medical Concepts (TMCI) Share-based Compensation (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 7 years of Share-based Compensation data on file, last reported at $8.0 million in Q1 2026.
- Quarterly Share-based Compensation fell 7.58% year-over-year to $8.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $243000.0 (down 99.24% YoY) and the FY2025 annual result came in at $4.1 million, down 86.6% from the prior year.
- Share-based Compensation grew to $8.0 million in Q1 2026, from -$25.4 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $9.6 million in Q2 2025 to a low of -$25.4 million in Q4 2025.
- A 5-year average of $3.8 million and a median of $5.9 million in 2023 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation jumped 250.5% — and 2025, when it tumbled 396.5%.
- Tracing TMCI's Share-based Compensation over 5 years: stood at $2.5 million in 2022, then surged by 138.18% to $5.9 million in 2023, then surged by 45.42% to $8.6 million in 2024, then tumbled by 396.5% to -$25.4 million in 2025, then jumped by 131.67% to $8.0 million in 2026.
- The last three Share-based Compensation figures came in at $8.0 million (Q1 2026), -$25.4 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Treace Medical Concepts | 290.12 Mn | 244.50 Mn | 35.61 Mn | 6.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.46 Mn |
| Jun 30, 2026 | 6.46 Mn |
| Mar 31, 2026 | 8.03 Mn |
| Mar 31, 2026 | 8.03 Mn |
| Dec 31, 2025 | -25.37 Mn |
| Dec 31, 2025 | -25.37 Mn |
| Sep 30, 2025 | 8.00 Mn |
| Sep 30, 2025 | 8.00 Mn |
| Jun 30, 2025 | 9.58 Mn |
| Jun 30, 2025 | 9.58 Mn |
| Mar 31, 2025 | 8.69 Mn |
| Mar 31, 2025 | 8.69 Mn |
| Dec 31, 2024 | 8.56 Mn |
| Dec 31, 2024 | 8.56 Mn |
| Sep 30, 2024 | 7.90 Mn |
| Sep 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 6.74 Mn |
| Jun 30, 2024 | 6.74 Mn |
| Mar 31, 2024 | 7.41 Mn |
| Mar 31, 2024 | 7.41 Mn |